Rhumbline Advisers Masimo Corp Transaction History

Rhumbline Advisers

  • $103 Billion
  • Q1 2024

A detailed history of Rhumbline Advisers transactions in Masimo Corp stock. As of the latest transaction made, Rhumbline Advisers holds 133,132 shares of MASI stock, worth $15.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
133,132
Previous 137,951 3.49%
Holding current value
$15.3 Million
Previous $16.2 Million 20.91%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024
SELL
$109.17 - $146.85 $526,090 - $707,670
-4,819 Reduced 3.49%
133,132 $19.6 Million
Q4 2023

Feb 08, 2024
SELL
$76.73 - $120.62 $351,269 - $552,198
-4,578 Reduced 3.21%
137,951 $16.2 Million
Q3 2023

Nov 09, 2023
SELL
$84.17 - $161.17 $1.39 Million - $2.65 Million
-16,455 Reduced 10.35%
142,529 $12.5 Million
Q2 2023

Aug 08, 2023
BUY
$155.24 - $196.47 $1.49 Million - $1.89 Million
9,627 Added 6.45%
158,984 $26.2 Million
Q1 2023

May 11, 2023
BUY
$146.03 - $184.54 $345,506 - $436,621
2,366 Added 1.61%
149,357 $27.6 Million
Q4 2022

Feb 14, 2023
BUY
$110.88 - $150.36 $688,121 - $933,134
6,206 Added 4.41%
146,991 $21.7 Million
Q3 2022

Nov 10, 2022
SELL
$125.58 - $169.38 $376,488 - $507,801
-2,998 Reduced 2.09%
140,785 $19.9 Million
Q2 2022

Aug 11, 2022
BUY
$112.97 - $151.71 $881,391 - $1.18 Million
7,802 Added 5.74%
143,783 $18.8 Million
Q1 2022

May 12, 2022
BUY
$135.71 - $284.87 $119,289 - $250,400
879 Added 0.65%
135,981 $19.8 Million
Q4 2021

Feb 10, 2022
BUY
$266.41 - $303.29 $659,631 - $750,946
2,476 Added 1.87%
135,102 $39.6 Million
Q3 2021

Nov 12, 2021
SELL
$249.0 - $285.24 $601,833 - $689,425
-2,417 Reduced 1.79%
132,626 $35.9 Million
Q2 2021

Aug 05, 2021
BUY
$208.49 - $248.2 $247,060 - $294,117
1,185 Added 0.89%
135,043 $32.7 Million
Q1 2021

May 06, 2021
SELL
$220.31 - $283.75 $858,327 - $1.11 Million
-3,896 Reduced 2.83%
133,858 $30.7 Million
Q4 2020

Feb 10, 2021
SELL
$223.82 - $271.35 $771,955 - $935,886
-3,449 Reduced 2.44%
137,754 $37 Million
Q3 2020

Nov 12, 2020
SELL
$209.49 - $246.81 $877,134 - $1.03 Million
-4,187 Reduced 2.88%
141,203 $33.3 Million
Q2 2020

Aug 13, 2020
BUY
$178.49 - $250.39 $2.63 Million - $3.69 Million
14,737 Added 11.28%
145,390 $33.1 Million
Q1 2020

May 06, 2020
SELL
$148.38 - $186.78 $151,199 - $190,328
-1,019 Reduced 0.77%
130,653 $23.1 Million
Q4 2019

Feb 05, 2020
SELL
$140.81 - $159.49 $139,542 - $158,054
-991 Reduced 0.75%
131,672 $20.8 Million
Q3 2019

Oct 23, 2019
SELL
$145.61 - $159.87 $316,701 - $347,717
-2,175 Reduced 1.61%
132,663 $19.7 Million
Q2 2019

Aug 14, 2019
BUY
$122.29 - $148.82 $194,930 - $237,219
1,594 Added 1.2%
134,838 $20.1 Million
Q1 2019

May 01, 2019
BUY
$102.78 - $138.28 $179,248 - $241,160
1,744 Added 1.33%
133,244 $18.4 Million
Q4 2018

Jan 31, 2019
BUY
$98.38 - $125.32 $3.63 Million - $4.63 Million
36,927 Added 39.05%
131,500 $14.1 Million
Q3 2018

Nov 07, 2018
SELL
$97.19 - $124.54 $188,548 - $241,607
-1,940 Reduced 2.01%
94,573 $11.8 Million
Q2 2018

Aug 06, 2018
BUY
$83.88 - $102.21 $381,989 - $465,464
4,554 Added 4.95%
96,513 $9.42 Million
Q1 2018

May 02, 2018
SELL
$82.06 - $95.19 $549,227 - $637,106
-6,693 Reduced 6.78%
91,959 $8.09 Million
Q4 2017

Feb 09, 2018
SELL
$84.49 - $90.09 $750,102 - $799,819
-8,878 Reduced 8.26%
98,652 $8.37 Million
Q3 2017

Nov 06, 2017
BUY
$81.79 - $96.62 $8.79 Million - $10.4 Million
107,530
107,530 $9.31 Million

Others Institutions Holding MASI

# of Institutions
368
Shares Held
42.4M
Call Options Held
187K
Put Options Held
254K
View Full List

About MASIMO CORP

MASI Quotes by TradingView
  • Ticker MASI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 52,530,200
  • Market Cap $6.03B
  • Description
  • Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...
More about MASI
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email